↑ parent activity group ·
research dossier →

RONAN THOMPSON FOUNDATION INC
PHOENIX, AZ · EIN 273409074 · Form 990 · FY2020 · NTEE G19 · Voluntary Health Associations · Micro (<$100K) · ronanfoundation.org
revenue
$73K
expenses
$88K
net assets
$780K
employees
0
volunteers
8
program ratio
83%
mission · from form 990

THE RONAN FOUNDATION IS DEDICATED TO RAISING AWARENESS AND FUNDING CUTTING (CONT'D ON SCH O) EDGE RESEARCH FOR CHILDHOOD CANCER. WE ARE COMMITTED TO FUNDING CLINICAL TRIALS TO REDUCE THE NUMBER OF CHILDREN AFFECTED BY CHILDHOOD CANCER, INCREASE SURVIVAL RATES AND MINIMIZE LONG TERM MEDICAL AND PSYCHOLOGICAL EFFECTS OF TREATMENT.

profile · synthesized from sources

The Ronan Thompson Foundation funds cutting-edge research to improve treatments for children with neuroblastoma, a highly aggressive form of childhood cancer. The organization focuses on increasing survival rates, reducing relapse, and minimizing treatment side effects by supporting clinical trials and promoting transparency in research funding. It was founded in memory of Ronan Thompson to advocate for better outcomes in childhood cancer care.

irs program accomplishments · form 990 part iii · fy2020

what they reported doing

Program narrative the organization filed with the IRS. Ordered by program spending.

  1. #1 primary $661
    PAID FOR AND DELIVERED GROCERIES TO APPROXIMATELY 40 FAMILIES WITH CHILDREN BATTLING CANCER THAT WERE IN NEED OF ASSISTANCE DURING THE COVID-19 PANDEMIC
named programs · 2 · from sources

what they call their work

Collaborative Research Initiative
Partners with other nonprofits and research institutions to co-fund high-impact clinical trials in pediatric oncology
Research Funding for Neuroblastoma Clinical Trials
Supports cutting-edge clinical research to improve treatment efficacy and survival rates for children with neuroblastoma, with a focus on relapsed cases
activities · 1 group

what they do

  • Pediatric & Specialty Disease Research Funding 2 activities
    • Funding neuroblastoma treatment research
      Funds cutting-edge research aimed at improving treatments for children with neuroblastoma.
    • Funding neuroblastoma treatment research
      Funds cutting-edge research aimed at improving treatments for children with neuroblastoma.
financials · form 990 · fy2020
revenue
Total revenue$73K
Contributions & grants$73K100%
Program service revenue$00%
Investment income$1810%
Other revenue$0
expenses
Total expenses$88K
Program expenses83%
Admin / overhead11%
Fundraising6%
Salaries & benefits$0
Grants paid out$73K
Largest expense lineFacilities
balance sheet
Total assets$780K
Cash$780K
Investments$0
Liabilities$0
Net assets$780K
Liquid reserves106.4 mo
1 years on record · 2020–2020
leadership · form 990 part vii · fy2020

who runs it

board members · 6
  • JULIE OGILVY — DIRECTOR(THRU 11/18/20)
  • MAYA THOMPSON — FOUNDER
  • MELISSA DIFLIPPO — TREASURER
  • RACHEL GOLDMAN — VICE PRESIDENT
  • STACY R FRAKES — DIRECTOR
  • WOODY THOMPSON — PRESIDENT
relationships · 5

who they work with

  • Children's Hospital of Philadelphia Partner — Dr. Yael Mosse, a Pediatric Oncologist, is on the executive board.
  • Give ID Partner — Partnered with Give ID to allow donors to track how their donation was used to fight cancer for kids.
  • Give ID Partner — Partners with Give ID to allow donors to choose which initiative to support and track how their donation was used.
  • NMRTC Partner — Dr. Giselle Sholler, Pediatric Oncologist and Chair of NMRTC, is on the executive board.
  • Phoenix Children's Hospital Partner — Dr. Aubrey Maze, a Pediatric Anesthesiologist, and Dr. Francis Eschun, a Pediatric Oncologist, are on the executive board.